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This study investigated the prevalence of feline haemoplasma infections in a number of stray cat colonies in Milan, Northern Italy.
Blood samples from 260 stray cats were evaluated, with conventional PCR, for the presence of DNA associated with Mycoplasma
haemofelis (Mhf) and “Candidatus Mycoplasma haemominutum” (CMhm). Odd ratios (OR) were calculated to identify risk factors
for haemoplasma infections. PCRwas positive in 86 out of 260 subjects (33.1%), with a prevalence of 10.8% (28/260 cats) forMhf and
22.3% (58/260 cats) for CMhm. No coinfections were registered.There were significant associations between infections and season
of sampling, that is, a negative association between winter sampling and a haemoplasma positive status (OR = 0.29, 𝑃 = 0.001), or
CMhm positive status (OR = 0.29, 𝑃 = 0.01). Haemoplasma infections are common in stray cats inMilan.Thus, domestic cats with
outdoor access should be routinely monitored and treated for ectoparasites to minimize risks of disease acquisition. Moreover, as
these infections are transmitted via blood, feline blood donors from this area should be screened by PCR and preferably be drawn
from a population of indoor cats regularly treated for fleas.
1. Introduction
Haemotropic mycoplasmas (haemoplasmas) are bacterial
organisms without cell walls that attach to and grow on the
surface of red blood cells. Three feline haemoplasma species
are described: Mycoplasma haemofelis (Mhf), “Candidatus
Mycoplasma haemominutum” (CMhm), and “Candidatus
Mycoplasma turicensis” (CMt) [1]. These feline haemoplas-
mas are the causative agents of infectious anemia in cats
and in several mammalian species. There is also potential
interspecies transmission of some of these agents as recorded
from cats to immunocompromised dogs [2]. Their zoonotic
potential has recently been substantiated by the molecular
identification of a feline haemoplasma isolate (Mhf) in an
HIV-positive immunocompromised human patient [3]. The
three feline haemoplasma species have different pathogenici-
ties, Mhf often resulting in haemolysis and severe anaemia in
contrast to CMhm and CMt which are less pathogenic [4].
Although several studies worldwide have reported on
the epidemiology of feline hemoplasmosis in sick or healthy
client-owned pet cats with prevalences ranging from 7.2% to
45.8% [5–19] and few studies have focused on stray cat (with
prevalences from 11.5% to 60% [20–24]), there have been no
studies investigating stray cats in Northern Italy. Information
on regional prevalence of haemoplasmas could be used to
limit the spread of diseases in feline populations and for
predicting the likelihood of infection in cats presented with
anemia.
The transmission of haemoplasmas is still poorly under-
stood. The vector potential of Ctenocephalides felis has been
demonstrated in experimental Mhf infections [25], and stray
cats may play a role in multiplying the organism in fleas
that then infest pet cats and dogs and human beings. Direct
transmission, by aggressive interaction of cats, or interspecies
transmission might play a role in the epidemiology of
these organisms. In addition, haemoplasmas can be directly
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transmitted through intravenous infusion of infected blood
[4, 26] and have been shown to survive for up to 1 week
in stored blood products [27]. As administration of fresh
or stored whole blood becoming more common in feline
medicine, the knowledge of the regional prevalence of blood
transmitted pathogens in owned and stray cats that share
the same environment and parasites is increasingly impor-
tant. This would provide useful information for evaluating
the risks of transmission of blood-borne infections from
potential blood donors and in the development of optimal
screening protocols in blood donors.
The aimof this studywas to evaluate, using a conventional
PCR assay, the prevalence of Mhf and CMhm infections in
stray cats from colonies in Milan and to identify possible risk
factors for these infections.
2. Materials and Methods
2.1. Sample Population and Data Collection. During a 2-
year collection period (January 2008 to January 2010), blood
samples were taken from 260 stray cats from urban colonies
inMilan (Northern Italy), under a trap-neuter-release (TNR)
program approved by the local authority of the city council.
The program was conducted as previously described [28, 29].
Age (estimated based on dentition, animals <6 months
of age were considered juvenile, whereas all others were
considered adult), gender (male or female), origin (prove-
nance area of colonies), and body condition score (BCS 4–
6, indicating normal weight, 1–3 underweight) were recorded
together with data obtained from physical examination of the
cats (healthy or unhealthy). Unhealthy cats were defined as
cats with one or more of the following clinical abnormalities:
lymph node enlargement, pale mucous membranes, stomati-
tis, or signs of ocular and respiratory infections.
The seasonal analysis based on the date of sample col-
lection was grouped as follows: winter (January, February,
and March), spring (April, May, and June), summer (July,
August, and September), autumn (October, November, and
December).The catswere not systematically examined for the
presence of ticks or fleas and so rates of ectoparasitism were
not recorded.
2.2. Haematological and Serological Analyses. Blood samples
were collected aseptically from the jugular vein while cats
were anaesthetized for neutering and placed in EDTA-treated
tubes and in serum separator tubes.
Within 24 h of sample collection, a complete blood count
(CBC) was performed on whole blood using an ADVIA 120
System (Siemens Healthcare Diagnostics, Milan, Italy). Cats
were categorized in terms of presence or absence of anaemia
(HCT < 24%), leukopenia (WBCs count < 10,570/𝜇L), leuko-
cytosis (WBC > 14,390/𝜇L), and thrombocytopenia (PLT <
200,670/𝜇L) [30]. Surplus blood was stored at −20∘C to use
later in PCR assay.
Following separation, serum samples were tested for
antibodies to FIV (relative to gp40 and p24 FIV antigens)
and for FeLV p27 antigen with a commercial enzyme-linked
immunosorbent assay (ELISA) kit (Snap FeLV/FIV Combo
Plus Test; Idexx Laboratories, Hoofddorp, The Netherlands).
Toxoplasma gondii sera IgG antibodies were detected using
indirect fluorescent antibody tests (IFAT) performed with
a commercial kit (Fuller-laboratories, Fullerton, CA, USA).
Titres ≥1 : 64 were considered seroreactive and, therefore,
indicative of T. gondii exposure. The results of these sero-
logical tests have been already published [28] and were
reanalyzed with the present results.
2.3. PCR Assay. Conventional PCR was performed on blood
samples to amplify DNA associated with haemoplasmas
(Mhf and CMhm). The reaction mixture included 2𝜇L of
template DNA, 0.25mM dNTPs, 0.4mM of each primer,
1x reaction buffer, and 2.5U Tap DNA polymerase (GoTaq
DNAPolymerase, Promega,Madison,WI,USA).The volume
of this mixture was adjusted to 25 𝜇L with sterile water.
Primers were used that target part of the 16S rRNA gene,
producing a 170 base pair (bp) product from Mhf and 193 bp
amplicon from MChm (forward primer, 5󸀠-ACG AAA GTC
TGA TGG AGC AAT A-3󸀠 and reverse primer 5󸀠-ACG CCC
AAT AAA TCC GRA TAA T-3󸀠) [6, 31]. PCR reactions were
performed using an automated thermocycler. PCR products
were resolved using 2% agarose gels and fragment size was
estimated using aDNAmolecular weightmarker (50 bpDNA
Ladder; Promega Madison, WI, USA). Control reactions
were done in the absence of template DNA to rule out
contaminations during PCR.
2.4. Statistical Analysis. Association between the three
groups of haemoplasma status (haemoplasma positive, Mhf
positive only, and CMhm positive only) and categorical
variables (age, gender, colony of origin, BCS, season of sam-
pling, health status, presence or absence of selected clinical
and CBC abnormalities, FeLV/FIV status, and T. gondii test
results) were analysed by univariate analysis using the chi-
squared test (cell frequencies of >5) or Fisher’s exact test
(cell frequencies of ≤5). Any parameters statistically linked to
positive PCR results were used in a logistic regression model
to test for independent risk factors associated with infection.
Descriptive statistics (including minimum, maximum,
mean, median, and standard deviation (SD)) were obtained
for the continuous variables RBCs count, HCT, HB, WBC
count, and PLT count values. Distribution of the data for
normality was assessed with Kolmogorov Smirnov test, and
a 𝑡-test or a Mann-Whitney 𝑈 test, respectively, was used to
test the differences between the feline haemoplasma positive
and negative cats depending on whether data was normally
distributed or not.
Associations were considered statistically significant
when 𝑃 < 0.05. Both the 𝑃 value and odds ratio (OR) with
95% confidence interval (CI) are reported. Data were ana-
lyzed using MedCalc Software (version 12.3.0; Mariakerke,
Belgium).
3. Results
Haemoplasmic DNA was detected in 33.1% (86/260, 95% CI
26.5–40.9%) of blood samples. Of the positive samples, 28
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Figure 1: HCT values of Italian stray cats grouped by haemoplasma
infectious status. Boxes represent the 25th, 50th (median), and 75th
quartiles withwhiskers extending to the greatest and smallest values.
Blue circles indicate outliers (cases with values greater than 1.5 box
lengths from the upper or lower edge of the box). CMhm: “Can-
didatus M. haemominutum” positive; Mhf: M. haemofelis positive.
The HCT values of CMhm group and the Mhf group were not
significantly lower than the negative group. The HCT values of the
Mhf group were also not significantly lower than the CMhm group.
cats (10.8%, 95%CI 7.2–15.6%) were infected withMhf and 58
cats (22.3%, 95% CI 16.9–28.8%) were infected with CMhm.
No comorbid infections were registered.
Characteristics of the population and association between
risk factors and haemoplasma PCR status (negative or pos-
itive) are reported in Table 1 and between Mhf alone and
CMhm alone positive results in Table 2.
None of the risk factors were associated with the PCR
results for haemoplasmas (Tables 1 and 2), with the excep-
tion of negative associations at univariate and multivariate
analysis between winter season of sampling and haemo-
plasma positive status (𝑃 = 0.01, OR = 0.29, 95% CI = 0.14–
0.61, 𝑃 = 0.001) and CMhm positive status (𝑃 = 0.01, OR =
0.29, 95% CI = 0.12–0.70, 𝑃 = 0.01).
CBC results from 150/260 cats are reported in Table 3.
Data was normally distributed according to Kolmogorov
Smirnov test. No significant associations were found with
CBC abnormalities and haemoplasma PCR-positive results
(Figure 1) or in the number of anaemic and nonanaemic cats
using a 𝑡-test.
4. Discussion
We present the first study investigating the prevalence of
haemoplasmas in urban stray colony cats from the city of
Milan in Northern Italy.
The prevalence of haemoplasma infection in our sample
showed a similar pattern to that reportedworldwide in client-
owned [5–7, 9–15, 17–19] and stray cats [19–23]. CMhm
infection is reported to be the most common infection,
ranging from 8% in Arizona [21] to 41.6% in Portugal
[19]; Mhf infection was less common ranging from 0.5% in
Switzerland [9] to 12.8% in Portugal [19] and dual infection
was absent or rare (no more than 5.4% as found in Korea)
[22].
The prevalence of haemoplasmas in stray cats in our
study (33.1%) was higher than that reported in other studies
on stray cats performed worldwide (Table 4). Differences in
prevalence among countries can be explained by geographical
variation, such as climate, vector distribution, and the cat
population surveyed.Moreover, direct comparisons of preva-
lence results are of limited value because of the characteristics
of sample of cat populations investigated (number of cats
included in the study, healthy versus sick cats), inclusion
criteria, diagnostic techniques (molecular tools versusmicro-
scopical detection), different statistical methods, stage of
infection (acute versus chronic), or a combination of all them,
resulting in differences between studies.
Stray cats in this study had higher rates of infections than
those reported for pet cats in Northern Italy [12], in which
18.9% of PCR tested cats were reported to be haemoplasma
positive. A high incidence of haemoplasmas in stray cats is
not surprising as outdoor access is a recognized risk factor for
infection. For example, in a study on haemoplasma in client-
owned cats fromBarcelona (Spain), outdoor accesswas found
to be a risk factor for infection (OR = 3.8) [15]. Additionally,
in a study involving feline blood donors from the USA, the
prevalence of haemoplasmas was 19.7% in domestic cats with
outdoor access and only 3.6% in domestic cats not allowed
outdoors [8]. Free-ranging cats may have more exposure
to bloodsucking arthropods and exhibit a higher fighting
activity than owned indoor cats; thus they might experience
a higher infection risk for haemoplasmas.
In our study there was a negative statistical association
between sampling in the winter season and haemoplasma
PCR-positive status and CMhm positive status. This may be
due to reduced outdoor activity of fleas in winter seasons,
although this hypothesis is purely speculative. There were
no statistically significant differences or any relationship
between the presence of haemoplasma infection and anaemia
status or HCT levels between positive and negative haemo-
plasma group. This finding was somewhat surprising and
was in agreement with studies undertaken in client-owned
cats in Switzerland [9] and in Italy [12], which also found
no association between haemoplasma infection and anaemia
or HCT variations. In addition, other studies have failed to
demonstrate a significant difference in prevalence rates of
haemoplasma between healthy and anaemic cats [10, 32].
These results could be explained by the higher prevalence
of CMhm (a less pathogenic species than Mhf) in this and
previous studies or by the fact that the stage of infection
is not known in our cats with a positive PCR result, since
chronically infected cats that recover from acute illness
may be asymptomatic. Another explanation for the lack of
association between infection status and the presence of
anaemia in the present study could be that the HCT was
known only for 150 of the 260 cats tested.
Epidemiological data on haemoplasma are particularly
important in areas where feline blood donor programmes
are active, as in Milan where a donor programme has been
running since 2010 at University Veterinary Transfusion Unit
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Table 1: Sample characteristics of 260 stray cats testing positive and negative for haemoplasma infection by conventional PCR in Northern
Italy.
Factor Category Total number PCR 𝑃 value
(%) Negative (%) Positive (%)
Origin of the cats
(𝑛 = 260)
Zone 1 3 (1.2%) 3/174 (1.7%) 0/86 (0.0%) 𝑃 = 0.54
Zone 2 11 (4.2%) 6/174 (3.4%) 5/86 (5.8%) 𝑃 = 0.57
Zone 4 108 (41.5%) 68/174 (39.1%) 40/86 (46.5%) 𝑃 = 0.31
Zone 5 12 (4.6%) 8/174 (4.6%) 4/86 (4.7%) 𝑃 = 0.77
Zone 6 27 (10.4%) 15/174 (8.6%) 12/86 (14.0%) 𝑃 = 0.27
Zone 7 55 (21.2%) 41/174 (23/6%) 14/86 (16.3%) 𝑃 = 0.23
Zone 8 22 (8.5%) 14/174 (8.0%) 8/86 (9.3%) 𝑃 = 0.92
Zone 9 22 (8.5%) 19/174 (10.9%) 3/86 (3.5%) 𝑃 = 0.07
Age (𝑛 = 260) Juvenile (≤6 months) 118 (45.4%) 81/174 (46.6%) 37/86 (43.0%) 𝑃 = 0.69
Adult (>6 months) 142 (54.6%) 93/174 (53.4%) 49/86 (57.0%)
Gender (𝑛 = 260) Male 90 (34.6%) 30/174 (17.2%) 60/86 (69.8%) 𝑃 = 0.37
Female 170 (65.4%) 144/174 (82.7%) 26/86 (30.2%)
BCS (𝑛 = 243) Poor (1–3/9) 18 (7.4%) 10/165 (6.1%) 8/78 (10.3%) 𝑃 = 0.37
Good (4–6/9) 225 (92.6%) 155/165 (93.9%) 70/78 (89.7%) 𝑃 = 0.54
Seasons (𝑛 = 260)
Winter 64 (24.6%) 54/64 (94.4%) 10/64 (15.6%)
P = 0.01
OR = 0.29
CI = 0.14–0.61
P = 0.001∗
Spring 69 (26.5%) 38/69 (55.1%) 31/69 (44.9%) 𝑃 = 0.09
Summer 31 (11.9%) 23/31 (74.2%) 8/31 (25.8%) 𝑃 = 0.54
Autumn 96 (36.9%) 59/96 (61.5%) 37/96 (38.5%) 𝑃 = 0.40
Health status (𝑛 = 260) Healthy 72 (27.7%) 47/174 (27.0%) 25/86 (29.1%) 𝑃 = 0.84
Unhealthy 188 (72.3%) 127/174 (73.0%) 61/86 (70.9%)
Clinical abnormalities in
unhealthy cats (𝑛 = 188)
Lymph node enlargement 133 (70.7%) 87/102 (85.3%) 46/86 (53.5%) 𝑃 = 0.69
Pale mucous membranes 14 (7.4%) 11/102 (10.8%) 3/86 (3.5%) 𝑃 = 0.51
Stomatitis 101 (53.7%) 71/102 (69.6%) 30/86 (34.9%) 𝑃 = 0.43
Signs of respiratory tract
infection 22 (11.7%) 12/102 (11.8%) 10/86 (11.6%) 𝑃 = 0.29
Signs of ocular infection 40 (21.3%) 26/102 (25.5%) 14/86 (16.3%) 𝑃 = 0.92
CBC abnormalities
(𝑛 = 150)
Anaemia 62 (41.3%) 33/91 (36.3%) 29/59 (49.2%) 𝑃 = 0.69
Leukopenia 15 (10.0%) 11/91 (12.1%) 4/59 (6.8%) 𝑃 = 0.56
Leukocytosis 5 (3.3%) 3/91 (3.3%) 2/59 (3.4%) 𝑃 = 0.66
Thrombocytopenia 10 (6.7%) 4/91 (4.4%) 6/59 (10.2%) 𝑃 = 0.30
FIV test results (𝑛 = 166) Positive 13 (7.8%) 8/102 (7.8%) 5/64 (7.8%) 𝑃 = 0.82
Negative 153 (92.2%) 94/102 (92.2%) 59/64 (92.2%)
FeLV test results
(𝑛 = 166)
Positive 6 (3.6%) 4/102 (3.9%) 2/64 (3.1%) 𝑃 = 0.90
Negative 160 (96.4%) 98/102 (96.1%) 62/64 (96.9%)
T. gondii test results
(𝑛 = 113)
Positive 31 (27.4%) 18/87 (20.7%) 13/46 (28.3%) 𝑃 = 0.92
Negative 82 (27.4%) 49/87 (56.3%) 33/46 (71.7%)
PCR: polymerase chain reaction, BCS: body condition score, CBC: complete blood count, CI: 95% confidence interval, OR: odds ratio, FeLV: feline leukemia
virus, and FIV: feline immunodeficiency virus.
𝑃 values in bold are statistically significant (𝑃 < 0.05).
∗Results from multivariate logistic regression analysis.
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Table 2: Characteristics of 28 Mhf PCR positive stray cats and 58 CMhm PCR positive stray cats in Northern Italy.
Factor Category PCR positive results
Mhf 𝑛 (%) 𝑃 value CMhm 𝑛 (%) 𝑃 value
Origin of the cats
Zone 1 0/3 (0.0%)
𝑃 = 0.63
0/3 (0.0%)
𝑃 = 0.47
Zone 2 1/11 (9.1%) 4/11 (36.4%)
Zone 4 12/108 (11.1%) 28/108 (25.9%)
Zone 5 1/12 (8.3%) 3/12 (25.0%)
Zone 6 6/27 (22.2%) 6/27 (22.2%)
Zone 7 5/55 (9.1%) 9/55 (16.4%)
Zone 8 2/22 (9.1%) 6/22 (27.3%)
Zone 9 1/22 (4.5%) 2/22 (9.1%)
Age Juvenile (≤6 months) 13/118 (11.0%) 𝑃 = 0.93 24/118 (20.3%) 𝑃 = 0.59
Adult (>6 months) 15/142 (10.6%) 34/142 (23.9%)
Gender Male 11/90 (12.2%) 𝑃 = 0.15 15/90 (16.7%) 𝑃 = 0.15
Female 17/170 (10.0%) 43/170 (25.3%)
BCS Poor (1–3/9) 3/18 (16.7%) 𝑃 = 0.46 5/18 (27.8%) 𝑃 = 0.84
Good (4–6/9) 191/225 (84.9%) 51/225 (22.7%)
Seasons
Winter 4/64 (6.3%) 𝑃 = 0.27 6/64 (9.4%)
P = 0.01
OR = 0.29∗
CI = 0.12–0.70∗
P = 0.01∗
Spring 10/69 (14.5%) 𝑃 = 0.35 21/69 (30.4%) 𝑃 = 0.08
Summer 2/31 (6.5%) 𝑃 = 0.60 6/31 (19.4%) 𝑃 = 0.85
Autumn 12/96 (12.5%) 𝑃 = 0.63 25/96 (26.0%) 𝑃 = 0.34
Health status Healthy 9/72 (12.5%) 𝑃 = 0.74 16/72 (22.2%) 𝑃 = 0.88
Unhealthy 19/188 (10.1%) 42/188 (22.3%)
Clinical abnormalities in
unhealthy cats
Lymph node enlargement 13/133 (9.8%) 𝑃 = 0.74 33/133 (24.8%) 𝑃 = 0.40
Pale mucous membranes 1/14 (7.1%) 𝑃 = 0.99 2/14 (14.3%) 𝑃 = 0.68
Stomatitis 11/101 (10.9%) 𝑃 = 0.88 19/101 (18.8%) 𝑃 = 0.35
Signs of respiratory tract infection 3/22 (14.1%) 𝑃 = 0.93 7/22 (31.8%) 𝑃 = 0.39
Signs of ocular infection 3/40 (7.5%) 𝑃 = 0.65 11/40 (27.5%) 𝑃 = 0.52
CBC abnormalities
Anaemia 7/69 (10.1%) 𝑃 = 0.81 22/69 (31.9%) 𝑃 = 0.69
Leukopenia 0/14 (0.0%) 𝑃 = 0.40 4/14 (28.6%) 𝑃 = 0.81
Leukocytosis 0/5 (0.0%) 𝑃 = 1.00 2/5 (40.0%) 𝑃 = 0.97
Thrombocytopenia 1/10 (10.0%) 𝑃 = 0.59 5/10 (50.0%) 𝑃 = 0.27
FIV test results Positive 1/13 (7.7%) 𝑃 = 0.83 4/13 (30.8%) 𝑃 = 0.84
Negative 15/150 (10.0%) 44/150 (29.3%)
FeLV test results Positive 1/6 (16.7%) 𝑃 = 0.90 1/6 (16.7%) 𝑃 = 0.81
Negative 15/157 (9.6%) 47/157 (29.9%)
T. gondii test results Positive 6/31 (19.4%) 𝑃 = 0.14 7/31 (22.6%) 𝑃 = 0.38
Negative 6/81 (7.4%) 27/81 (33.3%)
PCR: polymerase chain reaction; BCS: body condition score; CBC: complete blood count; CI: 95% confidence interval; OR: odds ratio; FeLV: feline leukemia
virus; FIV: feline immunodeficiency virus. 𝑃 values in bold are statistically significant (𝑃 < 0.05).
∗Results from multivariate logistic regression analysis.
(REV, Reparto di Medicina Emotrasfusionale Veterinaria).
Feline haemoplasmas can be directly transmitted by intra-
venous infusion of fresh EDTA-anticoagulated blood [26],
heparinized blood [4], and by infusion of blood stored
in CPDA-1 solution for 1 h (Mhf) and 1 week (CMhm)
[27]. Cats do not reliably eliminate the organism following
infection [26] and most infections with CMhm are chronic
and asymptomatic [1]. A significant number of asymptomatic
cats are positive for haemoplasma infection [16] and may
play a role, along with infected cats, in the maintenance
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Table 3: Selected haematological findings in subgroups of haemoplasma PCR-positive and PCR-negative cats.
Variable, reference range Number of cats Mean SD Median Lowest value Highest value
PCR-positive for all haemoplasma
WBC 59 11.019 4.427 10.720 1.558 23.240
RBC 59 6.406 1.059 6.300 2.100 8.750
HB 59 9.1 3.7 8.9 4.7 12.4
HCT 59 24.7 1.4 24.7 13.2 32.2
PLT 59 369 145 380 90 693
PCR-negative for all haemoplasma
WBC 91 10.815 3.957 10.440 1.516 22.870
RBC 91 6.555 1.113 6.550 3.780 9.190
HB 91 25.5 1.7 9.2 14.6 13.2
HCT 91 9.4 4.4 25.2 4.2 38.4
PLT 91 378 141 367 119 800
PCR-positive Mhf
WBC 15 10.547 3.062 9.990 6.400 15.460
RBC 15 6.541 800 6.310 5.610 8.460
HB 15 9.4 1.2 9.4 7.6 12.4
HCT 15 24.8 3.1 25.2 20.4 30.9
PLT 15 371 122 376 135 693
PCR-positive CMhm
WBC 43 11.181 4.825 10.790 1558 23.240
RBC 43 6.360 1.138 6.285 2.100 8.750
HB 43 9.0 1.5 8.9 4.7 12.1
HCT 43 24.6 4 24.5 13.2 32.2
PLT 43 369 154 386 90 662
WBC: white blood cell; RBC: red blood cells; HB: haemoglobin; HCT: haematocrit; PLT: platelet.
Table 4: Prevalence of haemoplasma infection in stray cats in
worldwide studies.
Sample source
(number of tested cats) [Ref]
Positive samples
Total prevalence Mhf CMhm
Italy current study (260) 33.1% 10.8% 22.3%
USA (Florida) (484) [20] 20.5% 8.3% 12.2%
Korea (331) [22] 14.5% 4.2% 10.3%
USA (Arizona) (112) [21] 27.7% 4.5% 8.0%
Ireland (75) [23] 17.3% 1.3% 13.3%
Canada (96) [24] 11.5% 3.1% 8.4%
Mhf:Mycoplasma haemofelis; CMhm: “Candidatus Mycoplasma haemomin-
utum.”
of haemoplasma infection within a population. All these
characteristics of feline haemotropic mycoplasma infection
need to be consideredwhen choosing potential blood donors.
The limitations of this study include the lack of infor-
mation on “Candidatus Mycoplasma turicensis” in our study
population. Risk factors analyzed were not available for
all 260 cats. Lastly, statistical analysis was limited in some
groups because of the sample size and so some conclusions
or associations may be affected by type I errors; that is,
no difference between haemoplasma positive and negative
groups was observed due to insufficient sample size; for
example, no association was recorded between anaemia and
a positive haemoplasma result because of the low number of
Mhf positive cats (28/260). Regardless of these limitations, we
believe that this study provides new and useful information
on feline haemoplasma infections in stray cats in Italy.
5. Conclusion
From this study it can be concluded that feline haemotropic
mycoplasma Mhf and CMhm are common in the stray cat
population of Milan. Indeed, pet cats with outdoor access
in this region should be regularly monitored and treated for
ectoparasites to minimize health risks. Importantly, feline
blood donors in this area should undergo PCR screening
for these infections before donations and preferably donors
should be drawn from exclusively indoor cats that receive
regular flea control.
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